Sincity Press | Your Inside Scoop on All Things Vegas – One Story at a Time!

Eubank outpoints bitter rival Benn in classic fight

Eubank outpoints bitter rival Benn in classic fight

Australia's universal healthcare is crumbling. Can it be saved?

Australia's universal healthcare is crumbling. Can it be saved?

TikTok to enter Japan e-commerce, Nikkei reports

TikTok to enter Japan e-commerce, Nikkei reports

Resilient England finally get test they needed

Resilient England finally get test they needed

Trump says American ships should be allowed to travel through the Panama and Suez canals for free

Trump says American ships should be allowed to travel through the Panama and Suez canals for free

Final Satoshi: Analyst Predicts Bitcoin's Endgame

Final Satoshi: Analyst Predicts Bitcoin's Endgame

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti

'Off days don't exist' for Celtic 'mentality monsters'

'Off days don't exist' for Celtic 'mentality monsters'

'Glasner's FA Cup heroes give Tuchel food for thought'

'Glasner's FA Cup heroes give Tuchel food for thought'

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

Latest

Eubank outpoints bitter rival Benn in classic fight

Eubank outpoints bitter rival Benn in classic figh...

2 days ago 1

Australia's universal healthcare is crumbling. Can it be saved?

Australia's universal healthcare is crumbling. Can...

2 days ago 2

TikTok to enter Japan e-commerce, Nikkei reports

TikTok to enter Japan e-commerce, Nikkei reports

2 days ago 2

Resilient England finally get test they needed

Resilient England finally get test they needed

2 days ago 1

Trump says American ships should be allowed to travel through the Panama and Suez canals for free

Trump says American ships should be allowed to tra...

2 days ago 3

Final Satoshi: Analyst Predicts Bitcoin's Endgame

Final Satoshi: Analyst Predicts Bitcoin's Endgame

2 days ago 2

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti

CG Oncology Announces Best-in-Disease Durability D...

2 days ago 4

'Off days don't exist' for Celtic 'mentality monsters'

'Off days don't exist' for Celtic 'mentality monst...

2 days ago 2

'Glasner's FA Cup heroes give Tuchel food for thought'

'Glasner's FA Cup heroes give Tuchel food for thou...

2 days ago 1

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

IO Biotech Showcases Scientific Leadership Through...

2 days ago 3

Wrexham's remarkable football rebirth - and what comes next

Wrexham's remarkable football rebirth - and what c...

2 days ago 4

What went wrong and what next for Ipswich?

What went wrong and what next for Ipswich?

2 days ago 3

Saudi Arabia reports record non-oil exports of $137 billion in 2024

Saudi Arabia reports record non-oil exports of $13...

2 days ago 3

Palestinian leader Abbas names likely successor in bid to reassure world powers

Palestinian leader Abbas names likely successor in...

2 days ago 3

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system

Medtronic Expand URO U.S. clinical trial meets saf...

2 days ago 1

Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC

Johnson & Johnson's TAR-200 monotherapy achieves h...

2 days ago 1

Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer

Johnson & Johnson's TAR-200 monotherapy demonstrat...

2 days ago 0

Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-NaÃ¯ve, High-Risk Non-Muscle Invasive Bladder Cancer

Pfizer's Sasanlimab Combination Significantly Impr...

2 days ago 0

Showing 414-432 of total 23352 entries.